A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease

被引:36
作者
McCurdy, Jeffrey D. [1 ,2 ]
Israel, Amanda [1 ]
Hasan, Maryam [1 ]
Weng, Robin [1 ]
Mallick, Ranjeeta [2 ]
Ramsay, Tim [2 ]
Carrier, Marc [2 ,3 ]
机构
[1] Ottawa Hosp, Div Gastroenterol, Ottawa, ON, Canada
[2] Ottawa Hosp, Ottawa Hosp Res Inst, Ottawa, ON, Canada
[3] Ottawa Hosp, Div Hematol, Ottawa, ON, Canada
关键词
MEDICAL PATIENTS; ULCERATIVE-COLITIS; RISK-FACTORS; THROMBOPROPHYLAXIS; PROPHYLAXIS; THROMBOSIS; DURATION; EVENTS; EPIDEMIOLOGY; METAANALYSIS;
D O I
10.1111/apt.15286
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Patients with inflammatory bowel disease (IBD) are at increased risk of venous thromboembolism (VTE) during hospitalisation and potentially post-discharge. Aims To determine the incidence and risk factors for post-discharge VTE in IBD patients and create a point of care predictive model to assess VTE risk. Methods Hospitalised IBD patients were identified from our institutional discharge database between 2009 and 2016, and were assessed for VTE by chart review. Risk factors for VTE within 3 months of discharge were determined by univariable and multivariable logistic regression. A point of care model was created using variables from the univariate analysis with P < 0.05, and internally validated by bootstrap methods. Results Sixty-six of 2161 eligible discharges (3%) were associated with VTE within 6 months of hospitalisation. The median time to event was 37 days (range 3-182 days). On multivariable analysis age >45 years (OR 3.76; 95% CI 1.80-7.89) and multiple admissions (OR 2.62; 95% CI 1.34-5.11) were independently associated with VTE risk. Our final model incorporated age >45 years, multiple admissions, intensive care unit admission, length of admission >7 days and central catheter and was able to discriminate between discharges associated with and without VTE (optimism-corrected c-statistic, 0.70; 95% CI 0.58-0.77). By limiting treatment to a high-risk group, extended thromboprophylaxis could be avoided in 92% of discharges with a miss rate of 1.6% (32/1982 discharges). Conclusion Patients with IBD remain at risk of VTE after hospital discharge. Our model may help clinicians stratify which patients will benefit most from extended thrombophrophylaxis.
引用
收藏
页码:1493 / 1501
页数:9
相关论文
共 50 条
[31]   Controversies in Venous Thromboembolism Risk Assessment in Inflammatory Bowel Disease: A Narrative Review [J].
Sharma, Nikhil ;
Tewatia, Pavit ;
Harvey, Philip R. ;
Kumar, Aditi .
DIAGNOSTICS, 2024, 14 (19)
[32]   Duration of Anticoagulation for the Management of Venous Thromboembolism in Inflammatory Bowel Disease: A Decision Analysis [J].
Nguyen, Geoffrey C. ;
Bernstein, Charles N. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (09) :1486-1495
[33]   Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism [J].
Scharrer, Susanna ;
Primas, Christian ;
Eichinger, Sabine ;
Tonko, Sebastian ;
Kutschera, Maximilian ;
Koch, Robert ;
Blesl, Andreas ;
Reinisch, Walter ;
Mayer, Andreas ;
Haas, Thomas ;
Feichtenschlager, Thomas ;
Fuchssteiner, Harry ;
Steiner, Pius ;
Ludwiczek, Othmar ;
Platzer, Reingard ;
Miehsler, Wolfgang ;
Tillinger, Wolfgang ;
Apostol, Sigrid ;
Schmid, Alfons ;
Schweiger, Karin ;
Vogelsang, Harald ;
Dejaco, Clemens ;
Herkner, Harald ;
Novacek, Gottfried .
INFLAMMATORY BOWEL DISEASES, 2021, 27 (11) :1773-1783
[34]   Physicians' Perceptions of Risks and Practices in Venous Thromboembolism Prophylaxis in Inflammatory Bowel Disease [J].
Sam, Justina J. ;
Bernstein, Charles N. ;
Razik, Roshan ;
Thanabalan, Reka ;
Nguyen, Geoffrey C. .
DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (01) :46-52
[35]   Venous Thromboembolism in Patients with Inflammatory Bowel Diseases: A Case-control Study of Risk Factors [J].
Scoville, Elizabeth A. ;
Konijeti, Gauree G. ;
Nguyen, Deanna D. ;
Sauk, Jenny ;
Yajnik, Vijay ;
Ananthakrishnan, Ashwin N. .
INFLAMMATORY BOWEL DISEASES, 2014, 20 (04) :631-636
[36]   Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease [J].
Faye, Adam S. ;
Hung, Kenneth W. ;
Cheng, Kimberly ;
Blackett, John W. ;
Mckenney, Anna Sophia ;
Pont, Adam R. ;
Li, Jianhua ;
Lawlor, Garrett ;
Lebwohl, Benjamin ;
Freedberg, Daniel E. .
INFLAMMATORY BOWEL DISEASES, 2020, 26 (09) :1394-1400
[37]   Contraception, Venous Thromboembolism, and Inflammatory Bowel Disease: What Clinicians (and Patients) Should Know [J].
Limdi, Jimmy K. ;
Farraye, Jennifer ;
Cannon, Rachel ;
Woodhams, Elisabeth ;
Farraye, Francis A. .
INFLAMMATORY BOWEL DISEASES, 2019, 25 (10) :1603-1612
[38]   Venous Thromboembolism Following Discharge from Hospital in Patients Admitted for Inflammatory Bowel Disease [J].
Harvey, Philip R. ;
Coupland, Benjamin ;
Mytton, Jemma ;
De Silva, Shanika ;
Trudgill, Nigel J. .
JOURNAL OF CROHNS & COLITIS, 2023, 17 (01) :103-110
[39]   Risk of venous thromboembolism in children and adolescents with inflammatory bowel disease: A systematic review and meta-analysis [J].
Zhang, Xin-Yue ;
Dong, Hai-Cheng ;
Wang, Wen-Fei ;
Zhang, Yao .
WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (16) :1705-1717
[40]   Adult-onset inflammatory bowel disease and the risk of venous thromboembolism - a Swedish nationwide cohort study 2007-2021 [J].
Broms, Gabriella ;
Forss, Anders ;
Eriksson, Julia ;
Askling, Johan ;
Eriksson, Carl ;
Halfvarson, Jonas ;
Linder, Marie ;
Sun, Jiangwei ;
Westerlund, Eli ;
Ludvigsson, Jonas F. ;
Olen, Ola .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2025, 60 (06) :526-535